Case Study: Pharmaceutical 

Pharmaceutical leader with large network of PET radiopharmacies uses CERDAAC to transform its operations in compliance with new FDA regulations.

What does a pharmaceutical company with millions of dollars invested in processes, people and equipment do when the entire industry’s compliance requirements suddenly change? That is the challenge one pharmaceutical company faced when its industry transitioned from oversight under the rules governing compounding pharmaceuticals to FDA regulatory compliance. The company, which owns and operates a large, global network of PET radiopharmacies, turned to SIMCO’s CERDAAC softwarefor the solution. Today, more than 400 employees across 43 sites in the US use SIMCO’s CERDAAC software to track the compliance of over 5,000 assets, as well as staff training and certification requirements.